alendronate has been researched along with Adult Periodontitis in 10 studies
alendronic acid : A 1,1-bis(phosphonic acid) that is methanebis(phosphonic acid) in which the two methylene hydrogens are replaced by hydroxy and 3-aminopropyl groups.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Alendronate (ALN) has antiresorptive and osteostimulative properties." | 6.87 | One percent alendronate and aloe vera gel local host modulating agents in chronic periodontitis patients with class II furcation defects: A randomized, controlled clinical trial. ( Dileep, P; Ipshita, S; Kumar, S; Kurian, IG; Pradeep, AR; Singh, P, 2018) |
| "Alendronate (ALN) increases alveolar bone density with systemic use and, has been found to increase bone formation on local delivery into the periodontal pocket." | 5.16 | Local drug delivery of alendronate gel for the treatment of patients with chronic periodontitis with diabetes mellitus: a double-masked controlled clinical trial. ( Bajaj, P; Kumari, M; Naik, SB; Pradeep, AR; Rao, NS; Sharma, A, 2012) |
| "The proposed therapy using Eplan and alendronate and alphacalcidolum based medicines increases the efficiency of periodontitis therapy, which allows for a faster relief of inflammation of periodontal tissues, bone tissue mineralization, long-term and sustainable disease regression." | 4.02 | [Metabolic bone tissue markers dynamics as criteria for periodontal disease treatment efficiency]. ( Abasnia, SR; Fadeeva, II; Kachesova, ES; Shevchenko, EA; Uspenskaya, OA, 2021) |
| "Alendronate (ALN) has antiresorptive and osteostimulative properties." | 2.87 | One percent alendronate and aloe vera gel local host modulating agents in chronic periodontitis patients with class II furcation defects: A randomized, controlled clinical trial. ( Dileep, P; Ipshita, S; Kumar, S; Kurian, IG; Pradeep, AR; Singh, P, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 7 (70.00) | 24.3611 |
| 2020's | 2 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| El Kilani, NS | 1 |
| Hazzaa, HH | 1 |
| Hemoud, HES | 1 |
| Imam, O | 1 |
| Gomes, EWB | 1 |
| Casarin, M | 1 |
| Martins, TM | 1 |
| da Silva, AF | 1 |
| Uspenskaya, OA | 1 |
| Kachesova, ES | 1 |
| Abasnia, SR | 1 |
| Shevchenko, EA | 1 |
| Fadeeva, II | 1 |
| Ipshita, S | 1 |
| Kurian, IG | 1 |
| Dileep, P | 1 |
| Kumar, S | 1 |
| Singh, P | 1 |
| Pradeep, AR | 5 |
| Kanoriya, D | 2 |
| Singhal, S | 2 |
| Garg, V | 2 |
| Manohar, B | 1 |
| Chatterjee, A | 1 |
| Guruprasad, CN | 1 |
| Akram, Z | 1 |
| Abduljabbar, T | 1 |
| Kellesarian, SV | 1 |
| Abu Hassan, MI | 1 |
| Javed, F | 1 |
| Vohra, F | 1 |
| Thomas, MV | 1 |
| Straus, SE | 1 |
| Sharma, A | 2 |
| Rao, NS | 1 |
| Bajaj, P | 1 |
| Naik, SB | 1 |
| Kumari, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Lepidium Sativum Extract Versus Simvastatin as an Adjunctive Local Delivery Agents to Non-Surgical Periodontal Therapy: A Randomized Controlled Clinical Trial With Biochemical Analysis[NCT05657015] | Phase 4 | 30 participants (Actual) | Interventional | 2021-09-01 | Completed | ||
| Effect of Alendronate With β - TCP Bone Substitute in Surgical Therapy of Periodontal Intra-osseous Defects: A Randomized, Controlled Clinical Trial.[NCT02795546] | Phase 4 | 32 participants (Actual) | Interventional | 2015-01-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for alendronate and Adult Periodontitis
| Article | Year |
|---|---|
Local delivery therapies as adjuvants to non-surgical periodontal treatment of periodontitis grade C: a systematic review.
Topics: Aggressive Periodontitis; Alendronate; Chronic Periodontitis; Dental Scaling; Humans; Periodontal In | 2020 |
Efficacy of bisphosphonate as an adjunct to nonsurgical periodontal therapy in the management of periodontal disease: a systematic review.
Topics: Administration, Oral; Administration, Topical; Alendronate; Chronic Periodontitis; Combined Modality | 2017 |
6 trials available for alendronate and Adult Periodontitis
| Article | Year |
|---|---|
Clinical and Radiographic Assessment of Single or Combined Treatment with Lepidium sativum and Alendronate of Non-Surgically Treated Chronic Periodontitis in Postmenopausal Osteoporotic Women.
Topics: ADAM Proteins; Alendronate; Chronic Periodontitis; Female; Humans; Lepidium sativum; Membrane Protei | 2019 |
One percent alendronate and aloe vera gel local host modulating agents in chronic periodontitis patients with class II furcation defects: A randomized, controlled clinical trial.
Topics: Adult; Alendronate; Bone Density Conservation Agents; Chronic Periodontitis; Dental Scaling; Female; | 2018 |
Comparative evaluation of subgingivally delivered 1% alendronate versus 1.2% atorvastatin gel in treatment of chronic periodontitis: a randomized placebo-controlled clinical trial.
Topics: Adult; Alendronate; Atorvastatin; Chronic Periodontitis; Double-Blind Method; Female; Follow-Up Stud | 2017 |
Synergistic Approach Using Platelet-Rich Fibrin and 1% Alendronate for Intrabony Defect Treatment in Chronic Periodontitis: A Randomized Clinical Trial.
Topics: Alendronate; Alveolar Bone Loss; Bone Density Conservation Agents; Chronic Periodontitis; Humans; Pe | 2016 |
Clinical efficacy of 1% alendronate gel as a local drug delivery system in the treatment of chronic periodontitis: a randomized, controlled clinical trial.
Topics: Adult; Alendronate; Alveolar Bone Loss; Bone Density Conservation Agents; Bone Regeneration; Chronic | 2012 |
Local drug delivery of alendronate gel for the treatment of patients with chronic periodontitis with diabetes mellitus: a double-masked controlled clinical trial.
Topics: Adult; Alendronate; Alveolar Bone Loss; Bone Density Conservation Agents; Bone Regeneration; Chi-Squ | 2012 |
2 other studies available for alendronate and Adult Periodontitis
| Article | Year |
|---|---|
[Metabolic bone tissue markers dynamics as criteria for periodontal disease treatment efficiency].
Topics: Alendronate; Alkaline Phosphatase; Bone and Bones; Chronic Periodontitis; Humans; Inflammation | 2021 |
Evidence-based dentistry and the concept of harm.
Topics: Alendronate; Bone Density Conservation Agents; Chronic Periodontitis; Clinical Competence; Databases | 2009 |